Abstract
BackgroundTenecteplase (TNK) is a genetically modified variant of alteplase (TPA) and has been established as a non-inferior alternative to TPA in acute ischemic stroke (AIS). Whether TNK exerts distinct benefits...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have